![Charles River Laboratories International, Inc. logo](/logos/CRL.webp)
Charles River Laboratories International, Inc.
NYSE:CRL
Overview | Financials
Company Name | Charles River Laboratories International, Inc. |
Symbol | CRL |
Currency | USD |
Price | 187.96 |
Market Cap | 9,704,506,372 |
Dividend Yield | 0% |
52-week-range | 161.65 - 275 |
Industry | Diagnostics & Research |
Sector | Healthcare |
CEO | Mr. James C. Foster J.D. |
Website | https://www.criver.com |
An error occurred while fetching data.
About Charles River Laboratories International, Inc.
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD